Herve Decousus

Summary

Country: France

Publications

  1. ncbi Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs
    Herve Decousus
    Service de Médecine et Thérapeutique, CHU Saint Etienne, France
    Best Pract Res Clin Haematol 25:275-84. 2012
  2. ncbi Superficial vein thrombosis: risk factors, diagnosis, and treatment
    Herve Decousus
    Groupe de Recherche sur la Thrombose, Université Jean Monnet, Saint Etienne, France
    Curr Opin Pulm Med 9:393-7. 2003
  3. ncbi Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis
    Herve Decousus
    INSERM, CIE3, Université Jean Monnet, EA3065, CHU Saint Etienne, Service de Médecine et Thérapeutique, Saint Etienne, F 42055 France
    Thromb Res 127:S81-5. 2011
  4. ncbi Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study
    Herve Decousus
    University Hospital, Saint Etienne, France
    Ann Intern Med 152:218-24. 2010
  5. ncbi Fondaparinux for the treatment of superficial-vein thrombosis in the legs
    Herve Decousus
    INSERM CIE3, F 42055, EA3065 Université Jean Monnet, and Service de Médecine et Thérapeutique, Centre Hôpitalier Universitaire Saint Etienne, Hopital Nord, Saint Etienne, France
    N Engl J Med 363:1222-32. 2010
  6. ncbi Thrombophilia and risk of venous thrombosis in patients with cancer
    Herve Decousus
    University Hospital, Saint Etienne, France
    Thromb Res 120:S51-61. 2007
  7. ncbi Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators
    Herve Decousus
    INSERM, CIE3, the University Saint Etienne, and CHU Saint Etienne, Hopital Nord, Service de Médecine Interne et Thérapeutique, Saint Etienne, France
    Chest 139:69-79. 2011
  8. ncbi Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis
    Sara Quenet
    Clinical Pharmacology Department, University Hospital Bellevue, Saint Etienne, France
    J Vasc Surg 38:944-9. 2003
  9. ncbi [Epidemiologic and therapeutic advances in superficial venous thrombosis of the legs]
    Laurent Bertoletti
    Groupe de Recherche sur la Thrombose, Université Jean Monnet, Saint Etienne
    Rev Prat 61:1244-8. 2011
  10. ncbi A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism
    Patrick Mismetti
    Thrombosis Research Group, CIC EC, Clinical Pharmacology Department, University Hospital, Saint Etienne, France
    Chest 131:223-9. 2007

Detail Information

Publications17

  1. ncbi Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs
    Herve Decousus
    Service de Médecine et Thérapeutique, CHU Saint Etienne, France
    Best Pract Res Clin Haematol 25:275-84. 2012
    ..The overall management of this frequent disease therefore needs to be reconsidered...
  2. ncbi Superficial vein thrombosis: risk factors, diagnosis, and treatment
    Herve Decousus
    Groupe de Recherche sur la Thrombose, Université Jean Monnet, Saint Etienne, France
    Curr Opin Pulm Med 9:393-7. 2003
    ..A one-month prophylactic dose of low molecular weight heparin plus elastic stockings could be the appropriate strategy in most cases. Other studies are needed before definitive conclusions can be drawn...
  3. ncbi Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis
    Herve Decousus
    INSERM, CIE3, Université Jean Monnet, EA3065, CHU Saint Etienne, Service de Médecine et Thérapeutique, Saint Etienne, F 42055 France
    Thromb Res 127:S81-5. 2011
    ..5 mg fondaparinux subcutaneously for 45 days on top of symptomatic treatments, may be proposed...
  4. ncbi Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study
    Herve Decousus
    University Hospital, Saint Etienne, France
    Ann Intern Med 152:218-24. 2010
    ..Superficial venous thrombosis (SVT) is perceived to have a benign prognosis...
  5. ncbi Fondaparinux for the treatment of superficial-vein thrombosis in the legs
    Herve Decousus
    INSERM CIE3, F 42055, EA3065 Université Jean Monnet, and Service de Médecine et Thérapeutique, Centre Hôpitalier Universitaire Saint Etienne, Hopital Nord, Saint Etienne, France
    N Engl J Med 363:1222-32. 2010
    ....
  6. ncbi Thrombophilia and risk of venous thrombosis in patients with cancer
    Herve Decousus
    University Hospital, Saint Etienne, France
    Thromb Res 120:S51-61. 2007
    ..Studies designed to assess the value of thromboprophylaxis in high-risk patients, including thrombophilic patients, with long-term central venous catheters may be valuable...
  7. ncbi Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators
    Herve Decousus
    INSERM, CIE3, the University Saint Etienne, and CHU Saint Etienne, Hopital Nord, Service de Médecine Interne et Thérapeutique, Saint Etienne, France
    Chest 139:69-79. 2011
    ....
  8. ncbi Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis
    Sara Quenet
    Clinical Pharmacology Department, University Hospital Bellevue, Saint Etienne, France
    J Vasc Surg 38:944-9. 2003
    ..Superficial vein thrombosis may be complicated with venous thromboembolism. We examined factors predictive of venous thromboembolism in superficial vein thrombosis, which, to our knowledge, had not been prospectively studied before...
  9. ncbi [Epidemiologic and therapeutic advances in superficial venous thrombosis of the legs]
    Laurent Bertoletti
    Groupe de Recherche sur la Thrombose, Université Jean Monnet, Saint Etienne
    Rev Prat 61:1244-8. 2011
    ..In absence of contra-indication, this treatment may be preferred in patients with confirmed isolated SVT of lower limb...
  10. ncbi A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism
    Patrick Mismetti
    Thrombosis Research Group, CIC EC, Clinical Pharmacology Department, University Hospital, Saint Etienne, France
    Chest 131:223-9. 2007
    ..The immediate and long-term clinical events associated with the placement and removal of a retrievable filter (ALN filter; ALN Implants Chirurgicaux; Ghisonaccia, France) remain largely unknown...
  11. ncbi Use of the Delphi method to facilitate antithrombotics prescription during pregnancy
    Celine Chauleur
    Gynaecology Obstetrics Department, EA3065 Thrombosis Research Group, University Hospital, 42055 Saint Etienne Cedex 2, Jean Monnet University, France
    Thromb Res 126:88-92. 2010
    ..Guidelines do not definitively fix optimal strategies due to limited trial data. Our objective was to build an easy-to-use tool allowing individualised, risk-adapted prophylaxis...
  12. ncbi Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women
    Celine Chauleur
    Gynaecology Obstetrics Department, EA3065 Thrombosis Research Group, University Hospital, 42055 Saint Etienne Cedex 2, France
    Thromb Res 122:478-84. 2008
    ..Our objective was to assess whether treatment based on risk score is feasible in these women...
  13. ncbi Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry
    Silvy Laporte
    Clinical Pharmacology Department, Thrombosis Research Group, EA 3065, University Hospital of Saint Etienne Bellevue, 42055 Saint Etienne Cedex 02, France
    Circulation 117:1711-6. 2008
    ..Clinical predictors for fatal pulmonary embolism (PE) in patients with venous thromboembolism have never been studied...
  14. ncbi [Initial treatment of venous thromboembolic events]
    Patrick Mismetti
    Service de Médecine Interne et Thérapeutique, Unite de Pharmacologie Clinique, Groupe de recherche sur la thrombose EA 3065 CIE3, CHU de Saint Etienne, 42055 Saint Etienne
    Rev Prat 57:751-7. 2007
    ....
  15. ncbi Optimal low-molecular-weight heparin regimen in major orthopaedic surgery. A meta-analysis of randomised trials
    Paul Zufferey
    Anesthesiology and Intensive Care Department, University Hospital of Saint Etienne, France
    Thromb Haemost 90:654-61. 2003
    ..03). These findings are tentative because the comparisons are across trials, but nevertheless suggest that the different LMWH regimens currently recommended are effective and safe...
  16. ncbi Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial
    Silvy Laporte
    Thrombosis Research Group, Clinical Pharmacological Department, University Hospital, Pavillon 5, F 42055 Saint Etienne Cedex 2, France
    Thromb Haemost 89:458-67. 2003
    ..No difference was found between the education groups. In patients starting oral anticoagulant therapy, dose determination may be the most important factor contributing to instability...
  17. ncbi Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Paul Zufferey
    Department of Anesthesiology and Intensive Care and EA3065, Thrombosis Research Group, University Hospital of Saint Etienne, Saint Etienne, France
    Anesthesiology 105:1034-46. 2006
    ..Although the results suggest that aprotinin and tranexamic acid significantly reduce allogeneic erythrocyte transfusion, further evaluation of safety is required before recommending the use of antifibrinolytics in orthopedic surgery...